Frost

Crexendo to Present at the AI & Technology Hybrid Investor Conference Presented by Water Tower Research on April 10

Retrieved on: 
Thursday, April 4, 2024

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

Key Points: 
  • If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
  • It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
  • Crexendo reported record Fiscal Year 2023 Results last month with robust revenue growth of 42% year-over-year finishing 2023 at $53.2M in revenue.
  • G2.com is the leading business software review website where users research and select solutions reviewed and recommended by real, verified customers.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 2, 2024

GLEN ALLEN, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2023 fiscal year ended December 31, 2023.

Key Points: 
  • GLEN ALLEN, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2023 fiscal year ended December 31, 2023.
  • Specifically, we conducted meetings and received favorable feedback from both US and European regulators, allowing us to refine our clinical development plan.
  • Cash and cash equivalents were $2.8 million as of December 31, 2023, compared to $4.0 million as of December 31, 2022.
  • Net Loss was $5.1 million for the year ended December 31, 2023, compared to a net loss of $12.7 million for the year ended December 31, 2022.

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

Retrieved on: 
Thursday, March 21, 2024

Price instability and cost increases will impact coffee drinkers worldwide, as more than 2 billion cups of coffee are drunk each day, 400 million of them by Americans.

Key Points: 
  • Price instability and cost increases will impact coffee drinkers worldwide, as more than 2 billion cups of coffee are drunk each day, 400 million of them by Americans.
  • Pluri’s cell-based coffee aims to reduce price instability by moving coffee production into the lab, eliminating the effect of climate change and adverse weather conditions.
  • Pluri recently announced the launch of its cell-based coffee , its proprietary cultured coffee product business, part of its PluriAgtech vertical, addressing the $130 billion coffee industry.
  • To learn more about Pluri’s coffee see the recent article titled “Cell-Based Coffee Future-Proofs World’s Favorite Brew” in the leading peer-reviewed journal Nature Biotechnology.

AdTheorent Holding Company, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Tuesday, March 12, 2024

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced fourth quarter and full-year 2023 financial results.

Key Points: 
  • NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced fourth quarter and full-year 2023 financial results.
  • Adjusted Gross Profit* was $39.9 million, an increase of $6.2 million, or 18.2%, compared to fourth quarter 2022.
  • Adjusted EBITDA* was $13.6 million, an increase of $3.5 million, or 34.8%, from $10.1 million in fourth quarter 2022.
  • Adjusted EBITDA* as a percentage of Adjusted Gross Profit* of 34.2% represented an increase from 30.0% in fourth quarter 2022.

SafeBreach Labs to Present Three Pieces of Original Research at Black Hat Asia 2024

Retrieved on: 
Wednesday, April 3, 2024

BLACK HAT ASIA 2024— SafeBreach , the pioneer in breach and attack simulation (BAS), today announced original research from its SafeBreach Labs team will be featured in three separate sessions at Black Hat Asia 2024 .

Key Points: 
  • BLACK HAT ASIA 2024— SafeBreach , the pioneer in breach and attack simulation (BAS), today announced original research from its SafeBreach Labs team will be featured in three separate sessions at Black Hat Asia 2024 .
  • SafeBreach’s Vice President of Security Research Tomer Bar and fellow researchers Or Yair and Shmuel Cohen are set to release a series of high-profile research pieces following a successful year at Black Hat USA 2023 and DEFCON 2023, where the SafeBreach Labs team presented an unprecedented five sessions.
  • The sessions at Black Hat Asia will include several significant discoveries exploring how endpoint detection and response (EDR) solutions and unfixed, known software issues can be exploited to present a significant security risk to enterprises.
  • For more information about the sessions and to connect with SafeBreach at Black Hat Asia 2024 on April 16-19, visit www.safebreach.com/events .

Wowza Expands Video On Demand Capability Within Its Market-Leading Live Streaming Offering

Retrieved on: 
Wednesday, April 3, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240403179232/en/
    The combination of Wowza's best-in-class live streaming capability with its newest video-on-demand services allows audience builders to maximize the value and reach of their video content, regardless of format.
  • “Our customers are constantly seeking new ways to connect with and monetize their audiences with video,” says Dave Stubenvoll, CEO of Wowza.
  • “Wowza has become one of the most respected brands in the video streaming technology industry, because we have remained deeply committed to the live video streaming space,” continues Stubenvoll.
  • (Source: Grand View Research, 2023 Video Streaming Market)
    Wowza is the experienced and trusted partner for reliable, scalable video solutions.

NICE Receives Frost & Sullivan’s 2023 Customer Value Leadership Award

Retrieved on: 
Tuesday, April 2, 2024

NICE (Nasdaq: NICE) today announced that it has received Frost & Sullivan’s 2023 Customer Value Leadership Award.

Key Points: 
  • NICE (Nasdaq: NICE) today announced that it has received Frost & Sullivan’s 2023 Customer Value Leadership Award.
  • Frost & Sullivan said that organizations benefit from NICE’s comprehensive roadmap that has always been deeply attuned to the evolving needs of the market.
  • Barry Cooper, President, CX Division, NICE, said, “NICE is committed to delivering solutions that address our customers’ most critical needs.
  • We are proud to receive this distinction from Frost & Sullivan, a true testament to what we continue to accomplish at NICE.”

NICE Recognized for European AI Product Innovation Industry Excellence

Retrieved on: 
Wednesday, March 27, 2024

NICE (Nasdaq: NICE) today announced it has received Frost & Sullivan’s 2024 Best Practices New Product Innovation Award for its ongoing advancements in AI for Customer Experience (CX) solutions for businesses across Europe.

Key Points: 
  • NICE (Nasdaq: NICE) today announced it has received Frost & Sullivan’s 2024 Best Practices New Product Innovation Award for its ongoing advancements in AI for Customer Experience (CX) solutions for businesses across Europe.
  • NICE excels in many of the criteria in the AI product innovation space.
  • Frost & Sullivan recognized NICE as an established global leader for CX AI technologies, with a strong track record of successful investments and a strategic vision, making AI a critical lever for achieving EX and CX excellence.
  • Darren Rushworth, President, NICE International, said, “Enlighten, NICE’s purpose-built AI for CX, is having a tremendous impact across EMEA and the world.

Genesys Announces Record Fiscal Year 2024 Business Results

Retrieved on: 
Thursday, March 21, 2024

Genesys ®, a global cloud leader in AI-powered experience orchestration, today reported a record-setting fiscal year 2024 (Feb. 1, 2023–Jan.

Key Points: 
  • Genesys ®, a global cloud leader in AI-powered experience orchestration, today reported a record-setting fiscal year 2024 (Feb. 1, 2023–Jan.
  • Genesys Cloud saw accelerated adoption of Genesys AI during the year, spanning conversational, generative and predictive capabilities.
  • Additionally, in February 2024, Genesys acquired Radarr Technologies , a leading AI-based social and digital listening, analytics, and consumer engagement company.
  • To further advance the company’s digital and AI innovations, Genesys invested $300 million in Genesys Cloud research and development during fiscal year 2024 and opened a new R&D center in Budapest during FY24.

Wolters Kluwer Redefines Clinical Decision Support for Tomorrow’s Healthcare

Retrieved on: 
Monday, March 11, 2024

Wolters Kluwer Health today unveiled the next generation of clinical decision support (CDS) solutions, bringing together point-of-care decision support, workflow optimization, and patient-centered care resources into unified, interoperable user experiences.

Key Points: 
  • Wolters Kluwer Health today unveiled the next generation of clinical decision support (CDS) solutions, bringing together point-of-care decision support, workflow optimization, and patient-centered care resources into unified, interoperable user experiences.
  • Wolters Kluwer Health has launched two tailored product experiences, serving different customers.
  • Products from both suites will be demonstrated at the Wolters Kluwer booth #2927, at the HIMSS24 Global Conference and Exhibition .
  • Watch this video to learn more about how Wolters Kluwer is redefining Clinical Decision Support for tomorrow’s healthcare.